>

DRAP demands explanation from UHS VC on COVID-19 vaccine trials

LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has sought an explanation from the University of Health Sciences (UHS) Vice-Chancellor (VC) for initiating clinical trials of vaccines without prior approval from Division of Pharmacy Services, DRAP.

In a note to UHS Vice-Chancellor Prof Dr Javed Akram, DRAP said University of Health Sciences neither applied to Director Division of Pharmacy Services/Chairman Clinical Committee to conduct clinical trials of vaccines nor any clinical trials have been approved by the committee. DRAP directed the UHS VC to stop clinical study on vaccines immediately and explain his position within three days for starting clinical trials without approval from the Clinical Study Committee, Division of Pharmacy Services, DRAP.

-DN Report

Dr Muattar Hanif

The author is Editor at Dental News Pakistan and can be reached at newsdesk@medicalnewsgroup.com.pk